argenx

ISIN US04016X1019

WKN A2H9WD

Market cap (in EUR)

49,194 m

Country

Netherlands

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Netherlands

Financials

Key metrics

Market capitalisation, EUR	49,194 m
EPS, EUR	-
P/B ratio	9.2
P/E ratio	43.3
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	2,021 m
Net income, EUR	769 m
Profit margin	38.03%

What ETF is argenx in?

There are 24 ETFs which contain argenx. All of these ETFs are listed in the table below. The ETF with the largest weighting of argenx is the First Trust NYSE Arca Biotechnology UCITS ETF Acc.

ETF	Weight	Investment focus	Fund size (in m EUR)
WisdomTree Megatrends UCITS ETF USD	0.07%	Equity World Social/Environmental Innovation	29
Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C 1C	0.10%	Equity World Social/Environmental Climate Change	37
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 1C	3.23%	Equity World Health Care Social/Environmental Innovation	7
First Trust NYSE Arca Biotechnology UCITS ETF Acc	3.24%	Equity United States Health Care Biotech	12
Amundi Prime Global UCITS ETF Acc	0.06%	Equity World	820
WisdomTree BioRevolution UCITS ETF USD Acc	1.05%	Equity World Health Care Social/Environmental Biotech	8
Invesco Nasdaq Next Generation 100 UCITS ETF Acc	1.35%	Equity United States Technology	32
Amundi Prime Global UCITS ETF Dist	0.06%	Equity World	1,339
Amundi Prime Europe UCITS ETF DR (D)	0.40%	Equity Europe	147
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.01%	Equity World Multi-Factor Strategy	139
Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF 1C 1C	1.47%	Equity Europe Social/Environmental Climate Change	8
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	2.16%	Equity United States Health Care Biotech	44
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.01%	Equity World Multi-Factor Strategy	755
iShares Nasdaq US Biotechnology UCITS ETF	2.16%	Equity United States Health Care Biotech	715
Amundi Prime All Country World UCITS ETF GBP Hedged Dist	0.06%	Equity World	-
Amundi Prime All Country World UCITS ETF Acc	0.06%	Equity World	485
L&G Global Equity UCITS ETF	0.07%	Equity World Social/Environmental	941
L&G Europe ex UK Equity UCITS ETF	0.50%	Equity Europe Social/Environmental	880
Amundi Prime Eurozone UCITS ETF DR (C)	0.74%	Equity Europe	74
Amundi Prime Eurozone UCITS ETF DR (D)	0.74%	Equity Europe	56
Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C	0.63%	Equity Europe Social/Environmental Climate Change	6
Amundi Prime All Country World UCITS ETF Dist	0.06%	Equity World	2,193
L&G Pharma Breakthrough UCITS ETF	2.81%	Equity World Health Care Innovation	16
Amundi Prime Europe UCITS ETF DR (C)	0.40%	Equity Europe	144

Change your settings